Llwytho...
Augmenting SRIs for OCD: Patient preference for risperidone does not limit effectiveness of exposure and ritual prevention
Patients with obsessive-compulsive disorder (OCD) often only partially respond to serotonin reuptake inhibitors (SRIs), the first-line pharmacotherapy for OCD. The American Psychiatric Association's Practice Guidelines suggest augmenting SRIs with either cognitive behavioral therapy consisting...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Psychother Psychosom |
|---|---|
| Prif Awduron: | , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5031481/ https://ncbi.nlm.nih.gov/pubmed/27513584 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000445356 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|